CANON 发表于 2025-3-23 11:51:31

Submitted on: 17 September 2011.
Revised on: 09 October 2011.
Accepted on: 30 October 2011.
NEURO-ONCOLOGY---OXFORD UNIV PRESS INC

TIGER 发表于 2025-3-23 17:39:49

http://reply.papertrans.cn/3/230/22964/22964-12.png

MAL 发表于 2025-3-23 18:22:57

Submitted on: 01 February 2015.
Revised on: 11 March 2015.
Accepted on: 07 April 2015.
NEURO-ONCOLOGY---OXFORD UNIV PRESS INC

MENT 发表于 2025-3-24 01:48:21

http://reply.papertrans.cn/3/230/22964/22964-14.png

Acclaim 发表于 2025-3-24 02:22:00

Submitted on: 27 May 2019.
Revised on: 13 June 2019.
Accepted on: 24 June 2019.
NEURO-ONCOLOGY

ABIDE 发表于 2025-3-24 09:50:59

Submitted on: 15 July 2001.
Revised on: 01 August 2001.
Accepted on: 22 August 2001.
NEURO-ONCOLOGY---OXFORD UNIV PRESS INC

nonchalance 发表于 2025-3-24 11:02:36

http://reply.papertrans.cn/3/230/22964/22964-17.png

tenosynovitis 发表于 2025-3-24 17:43:08

Submitted on: 12 July 2002.
Revised on: 06 August 2002.
Accepted on: 23 August 2002.
NEURO-ONCOLOGY

巧思 发表于 2025-3-24 22:29:38

http://reply.papertrans.cn/3/230/22964/22964-19.png

d-limonene 发表于 2025-3-25 01:17:26

Submitted on: 31 May 1999.
Revised on: 25 June 1999.
Accepted on: 30 June 1999.
NEURO-ONCOLOGY
页: 1 [2] 3 4
查看完整版本: SCIE期刊NEURO-ONCOLOGY 2024/2025影响因子:16.406 (NEURO-ONCOLOGY) (1522-8517). (CLINICAL NEUROLOGY)(临床神经病学)Science Citation In